D.C. Circuit Dismisses FTC Antitrust Suit: Exclusive Pharma Patent Licenses Remain … – Mondaq

United States: D.C. Circuit Dismisses FTC Antitrust Suit: Exclusive Pharma Patent Licenses Remain Permissible Under The Patent Act · Background · D.C. …